NCT06818136 - Bladder EpiCheck European Haematuria Study | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions

HematuriaCystoscopyUrothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma of the Urinary Bladder

Interventions

DIAGNOSTIC_TEST

Bladder EpiCheck

The participant will provide a voided urine sample, which will be tested using the Bladder EpiCheck test. The clinical care team and the participant will not be informed of the result, and the standard of care will not change.

Trial Locations (1)

Unknown

NHS Lothian, Edinburgh